437 related articles for article (PubMed ID: 7684745)
1. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease.
Gargosky SE; Hasegawa T; Tapanainen P; MacGillivray M; Hasegawa Y; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jun; 76(6):1631-7. PubMed ID: 7684745
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone (GH)-deficient patients: relationship with GH therapy.
Spagnoli A; Gargosky SE; Spadoni GL; MacGillivray M; Oh Y; Boscherini B; Rosenfeld RG
J Clin Endocrinol Metab; 1995 Dec; 80(12):3668-76. PubMed ID: 8530618
[TBL] [Abstract][Full Text] [Related]
3. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
[TBL] [Abstract][Full Text] [Related]
5. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
6. Urinary growth hormone (GH), insulin-like growth factor I (IGF-I), and IGF-binding protein-3 measurements in the diagnosis of adult GH deficiency.
Gill MS; Toogood AA; O'Neill PA; Thorner MO; Shalet SM; Clayton PE
J Clin Endocrinol Metab; 1998 Jul; 83(7):2562-5. PubMed ID: 9661643
[TBL] [Abstract][Full Text] [Related]
7. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting.
Gargosky SE; Pham HM; Wilson KF; Liu F; Giudice LC; Rosenfeld RG
Endocrinology; 1992 Dec; 131(6):3051-60. PubMed ID: 1280211
[TBL] [Abstract][Full Text] [Related]
8. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries.
Mason HD; Cwyfan-Hughes SC; Heinrich G; Franks S; Holly JM
J Clin Endocrinol Metab; 1996 Jan; 81(1):276-84. PubMed ID: 8550764
[TBL] [Abstract][Full Text] [Related]
10. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
Bang P; Brismar K; Rosenfeld RG; Hall K
J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance to maternal-embryonic and fetal interactions.
Nonoshita LD; Wathen NC; Dsupin BA; Chard T; Giudice LC
J Clin Endocrinol Metab; 1994 Nov; 79(5):1249-55. PubMed ID: 7525630
[TBL] [Abstract][Full Text] [Related]
12. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
Gargosky SE; Tapanainen P; Rosenfeld RG
Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
[TBL] [Abstract][Full Text] [Related]
13. Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure.
Lee DY; Park SK; Yorgin PD; Cohen P; Oh Y; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1376-82. PubMed ID: 7525635
[TBL] [Abstract][Full Text] [Related]
14. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
15. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
16. Not all insulin-like growth factor-binding proteins (IGFBPs) are detectable by western ligand blotting: case studies of PC12 pheochromocytoma and rat anterior pituitary IGFBPs and proteolyzed IGFBP-3.
Ocrant I; Fay CT; Pham H; Rosenfeld RG
Endocrinology; 1992 Jul; 131(1):221-7. PubMed ID: 1377122
[TBL] [Abstract][Full Text] [Related]
17. Urinary IGF and IGF binding protein-3 in children with disordered growth. The North West Paediatric Endocrine Group.
Gill MS; Whatmore AJ; Tillman V; White A; Addison GM; Price DA; Clayton PE
Clin Endocrinol (Oxf); 1997 Apr; 46(4):483-92. PubMed ID: 9196612
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid.
Matsumoto T; Gargosky SE; Iwasaki K; Rosenfeld RG
J Clin Endocrinol Metab; 1996 Jan; 81(1):150-5. PubMed ID: 8550744
[TBL] [Abstract][Full Text] [Related]
19. Inaccuracy of insulin-like growth factor (IGF) binding protein (IGFBP)-3 assessment in the diagnosis of growth hormone (GH) deficiency from childhood to young adulthood: association to low GH dependency of IGF-II and presence of circulating IGFBP-3 18-kilodalton fragment.
Cianfarani S; Liguori A; Boemi S; Maghnie M; Iughetti L; Wasniewska M; Street ME; Zucchini S; Aimaretti G; Germani D
J Clin Endocrinol Metab; 2005 Nov; 90(11):6028-34. PubMed ID: 16091488
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
